about
Cerebral amyloid angiopathy-related atraumatic convexal subarachnoid hemorrhage: an ARIA before the tsunamiPrevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers.APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls.Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer diseaseReduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid Aβ42 Levels in Cognitively Normal Elderly.Rapidly progressive dementia: experience in a tertiary care medical center.CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration.The frequency and influence of dementia risk factors in prodromal Alzheimer's disease.TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis.Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down Syndrome.CSF microRNA Profiling in Alzheimer's Disease: a Screening and Validation Study.Longitudinal brain structural changes in preclinical Alzheimer's disease.Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative Dementias.Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation.Copy number variation analysis of the 17q21.31 region and its role in neurodegenerative diseases.Cerebrospinal fluid mitochondrial DNA in the Alzheimer's disease continuum.Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory study.Performance and complications of lumbar puncture in memory clinics: Results of the multicenter lumbar puncture feasibility study.[(123)I-MIBG myocardial scintigraphy in the diagnosis of Lewy body dementia].Cerebrospinal fluid β-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer disease.Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer's disease.Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes.[Consensus statement on the clinical management of human immunodeficiency virus-associated neurocognitive disorders].Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease.Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.Weight loss in the healthy elderly might be a non-cognitive sign of preclinical Alzheimer's disease.Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia.Cortical microstructural changes along the Alzheimer's disease continuum.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.Cerebral changes and disrupted gray matter cortical networks in asymptomatic older adults at risk for Alzheimer's disease.Analysis of the CHCHD10 gene in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Spain.Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease.Remote cerebral hematomas in patients treated with intravenous rt-PA.A Common Variant in the MC1R Gene (p.V92M) is associated with Alzheimer's Disease Risk.Kidins220 Correlates with Tau in Alzheimer's Disease Brain and Cerebrospinal Fluid.Early Cerebellar Hypometabolism in Patients With Frontotemporal Dementia Carrying the C9orf72 Expansion.Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation.The pitfalls of biomarker-based classification schemes.
P50
Q35572825-6F4C5189-230A-40E5-9EB5-21533B6500EAQ35800785-0F1BE5DD-3276-4D3F-898A-72A1F50321A2Q35945633-821C91C1-FC9E-4D0E-B25F-EE5DA0C6DC94Q36413581-55CB23D5-7CF1-44A5-9F6D-C3CC3A588A82Q36756941-D892EA32-C04E-423F-AEED-4728DA0378D0Q37351277-A0D55CF8-9042-41E5-9EF6-6EB748F22AABQ37946069-F076F686-8799-402C-BEBF-01A0905998A9Q38375870-C234C6CF-68B2-47CE-89C4-6AEDCFCB6FD4Q38686461-D6D3B91E-3283-4DCC-A066-55E21F4EA44AQ38978510-6690C31D-0039-45F4-AC82-03232277882BQ39178216-8780F683-2758-418C-AAB2-850DC7AB02AEQ39293214-EC86DFC9-6003-44C0-93C5-E34D5C00B430Q39332197-A36710DF-FBC5-4640-AFFE-1AFE697F859DQ40196222-911764F4-B30A-45B1-BF5F-625DF2822306Q40239774-CCE1F058-6ED3-410C-9194-3F82783E70FFQ40321087-BABF0408-14CD-4A09-B2D2-5F1A0CD60524Q40435571-26A9606D-2EF0-4234-8383-D1AEC90B36CCQ40817419-AB25B5B4-0257-456B-8413-A27D69406298Q41362886-0A98CC6F-483D-46C3-95CA-7BD9CD2813CDQ42851403-567A57E3-2296-4645-9771-2CE4D5302E1EQ43593305-B6558EF6-FE9D-4723-8500-212C38BC607BQ44261310-681E48A5-D4C3-4583-B77B-8C6D7281C643Q44559507-38162F4C-90A3-4E3A-B419-8730397E4C60Q45927699-C8A5B8E4-79AD-45FA-A19C-ECBA5ECD01AEQ46629626-D64EE942-5721-4C93-A191-7BBD4720C7F4Q46759895-06D391E9-F646-4ACA-8445-5732CCDD988FQ46830133-2F265B1E-5D56-4A57-A68F-17393E8A57D5Q47134219-A4496D06-B93E-40FC-B58E-3D4BDD4B0AECQ47209262-5384D2E6-410D-4510-BBC5-63120E7B5635Q47231424-E20695DB-5BEA-4838-9BC5-DD56F391B202Q47587631-AAF786F8-2F48-48A4-9D67-5BAA7A5678D8Q47865617-14C42917-FEFD-45AA-BE3F-02AA5234F3FEQ48090963-48C55C58-022B-44F2-BB34-7B85386702F1Q48234063-7F994B9D-2DF5-42B2-9578-76D1B0BC03CFQ48316172-9360AC97-5E32-4176-A708-F57148392A65Q48369672-571D0290-D9B5-40D4-B4A1-3CEAA4FD1AFEQ48425790-D9FE86EC-6303-4DA3-892D-122D54D1FE74Q48555313-EEC5EFBA-38E1-4DDD-97F2-B0163FC7C4EBQ48824117-EB6F9F0B-D981-4F97-9345-6CE99A7A466CQ50202743-4BF522E7-C88D-4555-9689-B5E985E3EACA
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Daniel A. Alcolea
@ast
Daniel A. Alcolea
@en
Daniel A. Alcolea
@es
Daniel A. Alcolea
@sl
type
label
Daniel A. Alcolea
@ast
Daniel A. Alcolea
@en
Daniel A. Alcolea
@es
Daniel A. Alcolea
@sl
altLabel
Alcolea D
@en
Alcolea-Rodriguez D
@en
Daniel Alcolea Rodriguez
@en
Daniel Alcolea
@en
Daniel Alcolea-Rodriguez
@en
prefLabel
Daniel A. Alcolea
@ast
Daniel A. Alcolea
@en
Daniel A. Alcolea
@es
Daniel A. Alcolea
@sl
P106
P1153
35361516400
P2038
Daniel_Alcolea
P21
P31
P3835
daniel-alcolea
P496
0000-0002-3819-3245